Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
332
480 microg/kg daily (QD)
160 microg/kg daily (QD)
Placebo
Recovery of GI Function
Time frame: up to 7 days of dosing or until hospital discharge
Ancillary GI Functions
Time frame: up to 7 days of dosing or hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Fountain Valley Regional Hospital
Fountain Valley, California, United States
Orange Coast Memorial Med. Ctr.
Fountain Valley, California, United States
USC, Colorectal Surgery Division
Los Angeles, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Denver VA Medical Center
Denver, Colorado, United States
Nature Coast Clinical Research
Inverness, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Pensacola Research Consultants
Pensacola, Florida, United States
Sunrise Clinical Research, Inc.
Sunrise, Florida, United States
ARS Clinical Trials
Powder Springs, Georgia, United States
...and 35 more locations